These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3938686)

  • 1. Inappropriate TSH secretion with abnormal thyrotroph sensitivity to dopamine.
    Drucker D; Josse R
    Clin Invest Med; 1985; 8(2):117-20. PubMed ID: 3938686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin-releasing hormone and thyrotropin secretion.
    Utiger RD
    J Lab Clin Med; 1987 Mar; 109(3):327-35. PubMed ID: 3102657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine.
    Rösler A; Litvin Y; Hage C; Gross J; Cerasi E
    J Clin Endocrinol Metab; 1982 Jan; 54(1):76-82. PubMed ID: 6798060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthyroidism due to non-tumoural inappropriate TSH secretion. Effect of a long-acting somatostatin analogue (SMS 201-995).
    Williams G; Kraenzlin M; Sandler L; Burrin J; Law A; Bloom S; Joplin GF
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):42-6. PubMed ID: 2876571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin (TSH)-induced hyperthyroidism: response of TSH to dopamine and its agonists.
    Sriwatanakul K; McCormick K; Woolf P
    J Clin Endocrinol Metab; 1984 Feb; 58(2):255-61. PubMed ID: 6420433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are fasting-induced effects on thyrotropin and prolactin secretion mediated by dopamine?
    Röjdmark S
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1266-70. PubMed ID: 6404923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature.
    Spitz IM; Sheinfeld M; Glasser B; Hirsch HJ
    Postgrad Med J; 1984 May; 60(703):328-35. PubMed ID: 6429655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pyridostigmine on the thyroid-stimulating hormone response to thyrotropin-releasing hormone in abstinent alcoholics.
    Coiro V; Vescovi PP
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1308-11. PubMed ID: 9347094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperthyroidism due to a thyrotropin-secreting pituitary adenoma. Studies of thyrotropin and subunit secretion.
    Smith CE; Smallridge RC; Dimond RC; Wartofsky L
    Arch Intern Med; 1982 Sep; 142(9):1709-11. PubMed ID: 6810781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of thyrotropin (TSH) secretion to 3,5,3'-triiodothyronine and TSH-releasing hormone in rat during starvation.
    Hugues JN; Enjalbert A; Burger AG; Voirol MJ; Sebaoun J; Epelbaum J
    Endocrinology; 1986 Jul; 119(1):253-60. PubMed ID: 3087734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans.
    Coiro V; Volpi R; Capretti L; Caffarri G; Colla R; Chiodera P
    J Investig Med; 1999 May; 47(5):227-31. PubMed ID: 10361382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma free thyroid hormone concentrations in patients with nonthyroidal diseases.
    Maturlo SJ; Rosenbaum RL; Pan C; Surks MI
    J Clin Invest; 1980 Sep; 66(3):451-6. PubMed ID: 6772675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central hypothyroidism--various types of TSH responses to TRH stimulation.
    Trejbal D; Sulla I; Trejbalová L; Lazúrová I; Schwartz P; Machánová Y
    Endocr Regul; 1994 Mar; 28(1):35-40. PubMed ID: 7949012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal daily periodicity of serum thyrotropin (TSH) and evidence for defective TSH suppression in a case of non-neoplastic syndrome of inappropriate TSH secretion.
    Benvenga S; Sobbrio GA; Vermiglio F; Li Calzi L; Cannavò S; Consolo F; Trimarchi F
    J Endocrinol Invest; 1987 Apr; 10(2):195-202. PubMed ID: 3584859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of 100 micrograms TRH intravenously and 40 mg TRH orally in euthyroidism (author's transl)].
    Passath A; Stradner F; Petritsch W; Goebel ; Leb G
    Acta Med Austriaca; 1981; 8(3):75-81. PubMed ID: 6791450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of thyroid hormones with hypothalamic factors on pituitary TSH secretion.
    Nicoloff JT; Spencer CA
    Acta Med Austriaca; 1992; 19 Suppl 1():68-71. PubMed ID: 1519458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin I2 stimulates thyrotropin secretion in vivo and in vitro in rats.
    Mitsuma T; Nogimori T
    Endocrinol Exp; 1984 Mar; 18(1):53-8. PubMed ID: 6425038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.